C2N Diagnostics: Funding, Investors & Team (Oct 2026)
The mission of C2N Diagnostics is bringing Clarity Through InnovationTM. It centres its therapeutic discovery work on mechanisms-based strategies to halt or prevent the progression of human neurological illnesses. Accurate, widely available, and reasonably priced blood tests are being developed for use in clinics to improve patient care and track the health of the brain. The PrecivityADTM blood test, which is its main commercial offering, uses mass spectrometry to evaluate numerous analytes in blood, including A-42, A-40, and various isoforms of apolipoprotein E. Although the test alone cannot diagnose Alzheimer's disease, which must be confirmed clinically by a medical professional, it is a crucial new tool for doctors to use in the evaluation process.
C2N Diagnostics has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in Feb 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
C2N Diagnostics Company Profile and Key Stats
Latest funding round on record: Feb 2023.
C2N Diagnostics Funding Rounds
C2N Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
C2N Diagnostics Funding Compared to Other Biotechnology Startups
C2N Diagnostics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like C2N Diagnostics in Biotechnology and Saint Louis
Companies Similar to C2N Diagnostics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
C2N Diagnostics Funding FAQs
What does C2N Diagnostics do?
The mission of C2N Diagnostics is bringing Clarity Through InnovationTM. It centres its therapeutic discovery work on mechanisms-based strategies to halt or prevent the progression of human neurological illnesses. Accurate, widely available, and reasonably priced blood tests are being developed for use in clinics to improve patient care and track the health of the brain. The PrecivityADTM blood test, which is its main commercial offering, uses mass spectrometry to evaluate numerous analytes in blood, including A-42, A-40, and various isoforms of apolipoprotein E. Although the test alone cannot diagnose Alzheimer's disease, which must be confirmed clinically by a medical professional, it is a crucial new tool for doctors to use in the evaluation process.
How much funding has C2N Diagnostics raised?
C2N Diagnostics has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in Feb 2023.
When did C2N Diagnostics last raise funding?
C2N Diagnostics' most recent funding round on record is an undisclosed round of $15.0M, announced in Feb 2023.
Who founded C2N Diagnostics?
FundedIQ lists Joel Braunstein (Founder) at C2N Diagnostics.
Where is C2N Diagnostics headquartered?
C2N Diagnostics is based in Saint Louis, Missouri, United States.
How many employees does C2N Diagnostics have?
C2N Diagnostics is in the 11-50 employee band.
How does C2N Diagnostics' funding compare to other Biotechnology startups?
C2N Diagnostics' latest round of $15.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's C2N Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for C2N Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.